- Q1 2024 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 07, 2024€67.5Earnings
- Q4 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 27, 2024€78 (+13.87%)Earnings
- Ligand Pharmaceuticals Inc To Host Investor Day TranscriptDec 12, 2023
- Q3 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2023€49 (-1.21%)Earnings
- Q2 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2023€60 (+0.84%)Earnings
- Q1 2023 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023€68 (+0.74%)Earnings
- Q4 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 22, 2023€66.1 (-0.99%)Earnings
- Ligand Pharmaceuticals Inc Investor and Analyst Day TranscriptDec 13, 2022
- Q3 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 07, 2022€61.94 (-3.04%)Earnings
- Q2 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2022€59.17 (-0.04%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2022
- Q1 2022 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2022€55.04 (-2.91%)Earnings
- Q4 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 17, 2022€66.74 (-0.84%)Earnings
- Q3 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2021€81.37 (-1.18%)Earnings
- Q2 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 29, 2021€64.68 (+1.67%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 04, 2021
- Q1 2021 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 03, 2021€74.06 (-1.90%)Earnings
- Q4 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 03, 2021€93.16 (+2.79%)Earnings
- Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptDec 15, 2020
- Q3 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptOct 30, 2020€43.76 (-11.93%)Earnings
- Ligand Pharmaceuticals Inc Virtual Investor Day TranscriptOct 20, 2020
- Q2 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2020€63.74 (+2.32%)Earnings
- Ligand Pharmaceuticals Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- Q1 2020 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2020€57.38 (+3.26%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 06, 2020€52.52 (+0.60%)Earnings
- Q3 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptNov 05, 2019€63.15Earnings
- Q2 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptJul 30, 2019€59.9 (-1.37%)Earnings
- Q1 2019 Ligand Pharmaceuticals Inc Earnings Call TranscriptMay 02, 2019€69.76 (-0.18%)Earnings
- Ligand Pharmaceuticals Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Ligand Pharmaceuticals Inc Analyst Day TranscriptMar 12, 2019
- Ligand Pharmaceuticals Inc Announce Sale of Promacta Assets and Royalty to Royalty Pharma Call TranscriptMar 05, 2019
- Q4 2018 Ligand Pharmaceuticals Inc Earnings Call TranscriptFeb 07, 2019€63.24 (-2.09%)Earnings
Q2 2022 Ligand Pharmaceuticals Inc Earnings Call Transcript
Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Conference Call. My name is Vanessa, and I will be your operator for today's call.
(Operator Instructions)
Please note that this conference is being recorded. I will now turn the call over to your host, Simon Latimer. You may begin.
Thank you. Welcome to Ligand's Second Quarter of 2022 Financial Results and Business Update Conference call. Some of our speakers for today's call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.
We will use non-GAAP financial measures, and some of our statements will be forward looking, including those related to our financial condition, results of operations, financial guidance and the impact of the COVID-19 pandemic and the expected timing, completion and effects of our previously announced plans to spin off the OmniAb business to become a stand-alone public company pursuant to a business combination with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)